Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17320884 | 0.88 | EPHX1 (0.36) | EPHX1 | |
| SCHEMBL16541629 | 0.82 | EPHX1 (0.56) | EPHX1 | |
| SCHEMBL19214409 | 0.76 | EPHX1 (0.31) | EPHX1 | |
| SCHEMBL26216708 | 0.73 | EPHX1 (0.36) | EPHX1 | |
| SCHEMBL13672174 | 0.69 | EPHX1 (0.36) | EPHX1 | |
| SCHEMBL521656 | 0.67 | — | — | |
| SCHEMBL7131021 | 0.67 | EPHX1 (0.34) | EPHX1 | |
| SCHEMBL7131025 | 0.66 | EPHX1 (0.33) | EPHX1 | |
| SCHEMBL2054686 | 0.65 | — | — | |
| SCHEMBL2512663 | 0.65 | EPHX1 (0.48) | EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022264724-A1 | METHOD FOR PRODUCING POLYMER, AND COMPOUND, PALLADIUM COMPLEX, AND COMPOSITION | 住友化学株式会社 | 2022-12-22 | — | — | WO | disclosed |
| EP-4024486-A1 | ORGANIC PHOTOELECTRIC CONVERSION MATERIAL | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2022-07-06 | — | — | EP | disclosed |
| US-11045796-B2 | Process for producing aromatic compound, and palladium complex | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2021-06-29 | — | — | US | disclosed |
| US-10457792-B2 | Polarizing plate protective film, polarizing plate, and display device | FUJIFILM CORPORATION (JP) | 2019-10-29 | — | — | US | disclosed |
| US-9817156-B2 | Polarizing plate protective film, polarizing plate and display device | FUJIFILM CORPORATION (JP) | 2017-11-14 | — | — | US | disclosed |
| US-20170226317-A1 | POLARIZING PLATE PROTECTIVE FILM, POLARIZING PLATE, AND DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2017-08-10 | — | — | US | disclosed |
| US-20170226317-A1 | POLARIZING PLATE PROTECTIVE FILM, POLARIZING PLATE, AND DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2017-08-10 | — | — | US | disclosed |
| US-9512149-B2 | Reactive compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-12-06 | — | — | US | disclosed |
| US-9512149-B2 | Reactive compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-12-06 | — | — | US | disclosed |
| US-20150353583-A1 | REACTIVE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-12-10 | — | — | US | disclosed |
| US-20150353583-A1 | REACTIVE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11045796-B2 | Process for producing aromatic compound, and palladium complex | DDT, DRD1, DRD2 | EPHX1 2601/4885 |
| US-20150353583-A1 | REACTIVE COMPOUND | AR, AHR, ROS1 | EPHX1 3425/4885 |
| US-10457792-B2 | Polarizing plate protective film, polarizing plate, and display device | NBAS, SSB, GNA15 | EPHX1 1674/4885 |
| US-20170226317-A1 | POLARIZING PLATE PROTECTIVE FILM, POLARIZING PLATE, AND DISPLAY DEVICE | NBAS, SSB, BIRC5 | EPHX1 1892/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.